€1.00
1.38% yesterday
Brüssel, Jun 13, 05:12 pm CET
ISIN
BE0974340722
Symbol
SEQUA
Sector

Sequana Medical Stock price

€1.00
-0.02 2.14% 1M
+0.24 30.73% 6M
-2.06 67.19% YTD
-0.49 32.84% 1Y
-5.30 84.06% 5Y
-7.42 88.08% 10Y
-7.42 88.08% 20Y
Brüssel, Closing price Fri, Jun 13 2025
-0.01 1.38%
ISIN
BE0974340722
Symbol
SEQUA
Sector

Key metrics

Market capitalization €58.24m
Enterprise Value €94.54m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 859.45
P/S ratio (TTM) P/S ratio 529.45
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -84.51%
Revenue (TTM) Revenue €110.00k
EBIT (operating result TTM) EBIT €-18.22m
Free Cash Flow (TTM) Free Cash Flow €-20.35m
Cash position €3.81m
EPS (TTM) EPS €-1.20
P/S forward 89.60
EV/Sales forward 145.45
Show more

Is Sequana Medical a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Sequana Medical Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Sequana Medical forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Sequana Medical forecast:

Buy
100%

Financial data from Sequana Medical

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
0.11 0.11
85% 85%
100%
- Direct Costs 3.34 3.34
32% 32%
3,036%
-3.24 -3.24
22% 22%
-2,945%
- Selling and Administrative Expenses 7.37 7.37
16% 16%
6,700%
- Research and Development Expense - -
-
-
-18 -18
38% 38%
-16,009%
- Depreciation and Amortization 0.62 0.62
6% 6%
564%
EBIT (Operating Income) EBIT -18 -18
37% 37%
-16,566%
Net Profit -45 -45
37% 37%
-40,591%

In millions EUR.

Don't miss a Thing! We will send you all news about Sequana Medical directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sequana Medical NV is a commercial stage medical device company, which engages in the design, development, manufacture, and commercialization of medical device. The company focuses on the treatment solutions for the management of liver disease, heart failure, malignant ascites, and other fluid imbalance disorders. It offers alfapump, an implantable, programmable, wirelessly-charged, battery-powered system that manages refractory ascites and malignant ascites. The company was founded by Noel L. Johnson in 2006 and is headquartered in Ghent, Belgium.

Head office Belgium
CEO Ian Crosbie
Employees 48
Founded 2018
Website www.sequanamedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today